查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1848562

新生儿加护治疗呼吸器市场按产品类型、技术、模式、最终用户和应用划分－2025-2032年全球预测

Neonatal Intensive Care Respiratory Devices Market by Product Type, Technology, Mode, End User, Application - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，新生儿加护治疗呼吸设备市场规模将成长 69.8 亿美元，复合年增长率为 13.94%。

主要市场统计数据
基准年 2024 24.5亿美元
预计年份：2025年 28亿美元
预测年份：2032年 69.8亿美元
复合年增长率 (%) 13.94%

建构一个框架，用于阐述临床需求、创新和采购需求在新生儿呼吸设备采用过程中的策略交会点。

新生儿加护治疗中的呼吸设备格局正处于迫切的临床需求、快速的技术创新和不断演变的护理模式的交汇点。新生儿医学的进步提高了低出生体重儿的存活率，并提升了精准呼吸支持的重要性，这种支持需要在疗效和温和的肺保护治疗之间取得平衡。同时，对以家庭为中心的照护、早期拔管通讯协定和非侵入性策略的日益重视，正在重塑新生儿科室的设备选择、临床管道和采购重点。

临床医生、临床工程师和医院管理人员面临着各种复杂的设备和技术，从持续性气阳压呼吸器系统到高频人工呼吸器和氧气罩，每种设备和技术都有其独特的操作特性和培训要求。因此，采购者不仅要考虑临床疗效，还要考虑易用性、与监测平台的整合、耗材物流以及维护便利性。此外，监管和品质系统也日益影响设备的采用时间，要求製造商和供应商提供充分的证据、互通性和全生命週期支援。

在此背景下，市场参与企业正透过调整产品系列、采用模组化架构以及进行针对性临床研究来应对挑战，旨在检验设备在新生儿这一特殊人群中的表现。因此，有关设备采购、临床工作流程整合和投资的策略决策取决于对设备类型、技术差异以及不断变化的医疗服务模式的清晰理解。这种转变为后续分析组装，揭示了临床需求和营运实际情况如何共同驱动新生儿呼吸照护的需求动态和策略重点。

临床实务的模式转移：数位整合与供应链韧性如何重塑产品蓝图；监管预期与竞争动态；

新生儿呼吸照护正在经历变革时期，这场变革正在重新定义临床实践、产品设计和供应链模式。其中最显着的变化是从以有创通气为主的治疗方式转向更早期、更先进的非侵入性呼吸支持，这得益于设备创新，这些创新优先考虑同步性、漏气补偿和自适应控制演算法。这种转变反映了更广泛的临床需求，在最大限度减少肺损伤的同时，维持足够的气体交换，并正在推动产品渐进式改进和颠覆性新产品的涌现。

随着临床实践的不断发展，数位化和互联互通已成为核心差异化因素。能够与电子健康记录整合、提供高解析度波形分析并支援远端参数调节的设备正日益普及，因为它们支援数据驱动的医疗服务模式，并增强临床医生的情境察觉。此外，模组化硬体架构和软体升级策略使製造商能够在无需更换硬体的情况下持续提升产品效能，从而延长产品生命週期，并为医疗系统提供更大的灵活性。

供应链韧性和监管复杂性是进一步的变革力量。相关人员正在努力平衡本地製造措施与国际供应商网络，以确保符合不同的管理体制，同时降低地缘政治风险和关税的影响。同时，远距远端医疗、远距培训和云端基础分析的整合正在拓展新生儿呼吸护理的提供地点和方式，支持专业知识的去中心化，并使专科中心能够将监测范围扩展到其网路之外。这些转变并非渐进式的；它们正在重塑竞争动态、临床应用曲线以及医疗系统对设备供应商的期望。

评估美国关税调整对新生儿呼吸设备采购和供应链策略的营运和采购影响

美国在2025年前的关税调整为新生儿呼吸设备製造商、经销商和采购机构带来了新的考量。关税调整将影响到岸成本、供应商选择和垂直整合策略，促使企业重新评估其生产布局和采购决策。对于依赖跨境零件流通或成品进口的跨国供应商而言，关税可能会增加定价策略和合约谈判的复杂性。

为此，一些製造商正在加速近岸外包，并寻找替代供应商，以保护净利率并降低政策突变带来的风险。医疗系统客户也在重新思考其分销模式，包括长期合约、基于价值的服务组合以及本地库存寄售安排，以保护其客户免受价格波动的影响。此外，医院和专科医疗中心的采购团队正在将关税风险纳入总体拥有成本 (TCO) 分析和供应商风险评估，提高供应链透明度，并探索关键物资的紧急计画。

值得注意的是，关税的影响因设备类别和组件类型而异。软体密集、专有硬体有限的设备受到的影响可能小于依赖国际采购的专用组件的机械密集型系统。因此，相关人员正在优先考虑情境规划、敏感度分析和合约保护，以确保在各种政策结果下都能获得必要的新生儿呼吸技术。这些调整正在影响新生儿专案的采购计画和资本规划决策。

产品类型、技术模式、临床模式、可操作的细分洞察，将最终用户和应用与采购和临床决策联繫起来

关键的细分洞察揭示了设备选择、临床工作流程和采购决策如何受到产品、技术、模式、最终用户和应用等因素的影响。根据产品类型，临床团队和采购负责人会评估以下设备：用于无创支持和早期呼吸稳定的持续气道正压通气（CPAP）设备；用于常规有创支持的传统人工呼吸器；用于特殊肺復张和精细新生儿肺部管理的高频人工呼吸器；以及用于间歇性氧气疗法和对接口要求极低的氧气罩。这些产品差异决定了临床通讯协定、培训、耗材库存和维修流程。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 将人工智慧演算法整合到新生儿人工呼吸器预测管理中
  • 采用高流量氧气鼻管系统减少早产儿的侵入性通气
  • 开发一种可携式新生儿人工呼吸器，使婴儿能够在家中获得呼吸支持
  • 建构用于远端监测新生儿呼吸治疗的即时无线监测平台
  • 精准氧合模组的进步可优化新生儿呼吸结局
  • 美国FDA加速核准流程促进新生儿加护治疗呼吸器创新
  • 将抗菌和生物相容性涂层整合到人工呼吸器介面中，以防止感染
  • 新生儿加护病房对环保一次性呼吸耗材的需求不断增长
  • 为农村和医疗资源匮乏地区引入远端医疗新生儿呼吸机
  • 用于新生儿人工呼吸器的奈米材料过滤器可改善空气品质和安全性

第六章美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 新生儿加护治疗呼吸设备市场（依产品类型划分）

  • 持续性正压呼吸装置
  • 传统人工呼吸器
  • 高频人工呼吸器
  • 氧气罩

9. 按技术分類的新生儿加护治疗呼吸器市场

  • 侵入性呼吸支持
    • 传统机械人工呼吸器
      • 双控通风
      • 压力控制通气
      • 容量控制通气
    • 高频振盪通气
  • 非侵入性呼吸辅助
    • 持续性气道正压通气
    • 非侵入性正压通气

第十章 新生儿加护治疗呼吸器市场（依模式划分）

  • 双控通风
  • 压力控制通气
  • 容量控制通气

第十一章 新生儿加护治疗呼吸器市场（依最终用户划分）

  • 诊所
  • 医院
  • 专业护理中心

第十二章 新生儿加护治疗呼吸器市场（依应用领域划分）

  • 呼吸暂停监测
  • 氧气疗法
  • 提款援助

第十三章 各地区新生儿加护治疗呼吸器市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 新生儿加护治疗呼吸器市场（依类别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 各国新生儿加护治疗呼吸器市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Koninklijke Philips NV
    • General Electric Company
    • Dragerwerk AG & Co. KGaA
    • Medtronic plc
    • Fisher & Paykel Healthcare Corporation Limited
    • Hamilton Medical AG
    • Smiths Group plc
    • Becton, Dickinson and Company
    • ResMed Inc.
    • Natus Medical Incorporated
Product Code: MRR-925E8149CBB7

The Neonatal Intensive Care Respiratory Devices Market is projected to grow by USD 6.98 billion at a CAGR of 13.94% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 2.45 billion
Estimated Year [2025] USD 2.80 billion
Forecast Year [2032] USD 6.98 billion
CAGR (%) 13.94%

Framing the strategic intersection of clinical urgency technological innovation and procurement imperatives shaping neonatal respiratory device adoption

The neonatal intensive care landscape for respiratory devices sits at the intersection of acute clinical need, rapid technological innovation, and evolving care models. Advances in neonatal medicine have extended survival at increasingly lower gestational ages, elevating the importance of precision respiratory support that balances efficacy with gentle, lung-protective therapy. In parallel, increasing emphasis on family-centered care, early extubation protocols, and non-invasive strategies is reshaping device selection, clinical pathways, and procurement priorities across neonatal units.

Clinicians, clinical engineers, and hospital administrators face a complex array of devices and technologies, from continuous positive airway pressure systems to high-frequency ventilators and oxygen hoods, each with unique operational characteristics and training requirements. Consequently, purchasers must weigh not only clinical outcomes but also usability, integration with monitoring platforms, consumable logistics, and serviceability. Furthermore, regulatory scrutiny and quality systems increasingly influence time-to-adoption, requiring manufacturers and providers to demonstrate robust evidence, interoperability, and lifecycle support.

Against this backdrop, market participants are responding through product portfolio adaptation, modular architectures, and targeted clinical studies that seek to validate device performance in delicate neonatal populations. As a result, strategic decisions about procurement, clinical workflow integration, and investment hinge on a clear understanding of device modalities, technology differentiation, and shifting care delivery patterns. This introduction frames the subsequent analysis by highlighting how clinical imperatives and operational realities jointly drive demand dynamics and strategic priorities in neonatal respiratory care.

How clinical paradigm shifts digital integration and supply chain resilience are jointly reshaping product roadmaps regulatory expectations and competitive dynamics

The neonatal respiratory device landscape is undergoing transformative shifts that are redefining clinical practice, product design, and supply chain models. Foremost among these transformations is the migration from primarily invasive ventilation approaches toward earlier and more sophisticated non-invasive respiratory support, supported by device innovations that prioritize synchrony, leak compensation, and adaptive control algorithms. This shift reflects a broader clinical imperative to minimize lung injury while maintaining adequate gas exchange, and it has catalyzed both incremental product improvements and disruptive new entrants.

Concurrent with clinical evolution, digitalization and connectivity have become core differentiators. Devices that integrate with electronic medical records, provide high-resolution waveform analytics, and enable remote parameter adjustments are gaining traction because they support data-driven care pathways and enhance clinician situational awareness. Moreover, modular hardware architectures and software-upgrade strategies are enabling manufacturers to deliver ongoing performance enhancements without wholesale hardware replacement, thereby extending product lifecycles and offering greater flexibility to health systems.

Supply chain resilience and regulatory complexity represent additional transformative forces. Stakeholders are balancing local manufacturing initiatives with international supplier networks to mitigate geopolitical risk and tariff exposure while ensuring compliance with diverse regulatory regimes. Meanwhile, the convergence of telemedicine support, remote training, and cloud-based analytics is expanding where and how neonatal respiratory care can be delivered, supporting decentralization of expertise and enabling specialty centers to extend oversight across networks. Taken together, these shifts are not merely incremental; they are restructuring competitive dynamics, clinical adoption curves, and the expectations health systems place on device vendors.

Assessing the operational and procurement consequences of United States tariff adjustments for neonatal respiratory device sourcing and supply chain strategies

Tariff changes in the United States for the year 2025 have introduced new considerations for manufacturers, distributors, and purchasing organizations involved in neonatal respiratory devices. Tariff adjustments affect landed cost, supplier selection, and vertical integration strategies, prompting firms to re-evaluate manufacturing footprints and sourcing decisions. For multinational suppliers that rely on cross-border component flows or finished-goods imports, tariffs can increase the complexity of pricing strategies and contract negotiations.

In response, some manufacturers are accelerating nearshoring initiatives and qualifying alternate suppliers to preserve margin and reduce exposure to sudden policy shifts. Others are reassessing distribution models to insulate health system customers from abrupt price variability, offering long-term contracts, value-based service bundles, or locally stocked consignment arrangements. Additionally, procurement teams within hospitals and specialty care centers are factoring tariff risk into total cost of ownership analyses and supplier risk profiles, seeking greater transparency in supply chains and contingency planning for critical consumables.

Importantly, tariff impacts vary across device categories and component intensities. Devices with high software content and limited proprietary hardware may be less affected than mechanically intensive systems that rely on specialized components sourced internationally. Consequently, stakeholders are prioritizing scenario planning, sensitivity analyses, and contractual protections that preserve access to essential neonatal respiratory technologies under a range of policy outcomes. These adaptive measures are shaping procurement timelines and capital planning decisions across neonatal programs.

Actionable segmentation insights that link product typologies technology modalities clinical modes end users and applications to procurement and clinical decision making

Key segmentation insights reveal how device selection, clinical workflow, and purchasing decisions are shaped by distinct product, technology, mode, end user, and application considerations. Based on Product Type, clinical teams and procurement officers evaluate Continuous Positive Airway Pressure Devices for non-invasive support and early respiratory stabilization, Conventional Ventilators for routine invasive support, High-Frequency Ventilators for specialized recruitment and delicate neonatal lung management, and Oxygen Hoods for intermittent oxygen therapy and minimal interface needs. These product distinctions determine not only clinical protocols but also training, consumable inventories, and maintenance routines.

Based on Technology, market behaviors diverge between Invasive Respiratory Support and Non-Invasive Respiratory Support. Within invasive approaches, Conventional Mechanical Ventilation and High-Frequency Oscillatory Ventilation present differing technical demands and monitoring requirements. Diving deeper, Conventional Mechanical Ventilation encompasses Dual-Controlled Ventilation, Pressure Controlled Ventilation, and Volume Controlled Ventilation, each delivering distinct clinician control paradigms and safety considerations. Non-invasive alternatives include Continuous Positive Airway Pressure Therapy and Non-Invasive Positive Pressure Ventilation, which influence nursing workload, skin integrity protocols, and family interaction models.

Based on Mode, the operational profile of devices varies with Dual-Controlled Ventilation, Pressure Controlled Ventilation, and Volume Controlled Ventilation, driving differences in alarm management, clinician expertise required, and the suitability of devices for incremental weaning strategies. Based on End User, purchasing and utilization patterns differ across Clinics, Hospitals, and Specialty Care Centers, with each setting balancing capital intensity, in-house expertise, and patient acuity. Finally, based on Application, device selection is informed by clinical use cases such as Apnea Monitoring, Oxygen Therapy, and Weaning Support, which determine monitoring integrations, patient selection criteria, and protocolized care bundles. Recognizing these layered segmentation dynamics enables stakeholders to align product roadmaps, training investments, and procurement specifications with the real-world needs of neonatal care teams.

How regional healthcare maturity infrastructure and regulatory diversity shape device adoption procurement strategies and manufacturer go to market models across global regions

Regional dynamics critically influence adoption patterns, regulatory navigation, and supply chain planning for neonatal respiratory devices. In the Americas, demand drivers include advanced neonatal networks, emphasis on evidence-based protocols, and substantial capital investment capacity within tertiary hospitals and specialty centers. These factors together encourage adoption of feature-rich ventilators and integrated monitoring platforms, while payers and health systems seek demonstrable clinical and operational benefits to justify procurement decisions.

In Europe Middle East & Africa, diverse regulatory frameworks and wide variations in healthcare infrastructure create a market where modularity and serviceability are often prioritized. In higher-resourced markets within the region, integration with hospital IT systems and advanced ventilation modes are important, whereas in lower-resourced contexts, robustness, ease of maintenance, and local training support become decisive factors. As a result, manufacturers often tailor distribution models and post-sale services to accommodate this heterogeneity.

In Asia-Pacific, a combination of expanding neonatal care capacity, rapid hospital construction, and rising clinical expertise is generating demand for both high-end ventilators in tertiary centers and cost-effective, reliable devices for regional hospitals and specialty centers. Moreover, regional manufacturing initiatives and partnerships with local distributors are shaping competitive dynamics, as vendors seek to balance price sensitivity with the need for advanced features and regulatory alignment. These regional distinctions influence product positioning, go-to-market strategies, and the prioritization of clinical evidence to support adoption.

Competitive and strategic patterns among device manufacturers emphasizing clinical validation modular architectures service innovation and partnership driven go to market approaches

Insights into the competitive and strategic behavior of leading companies highlight several prevailing approaches that are shaping the neonatal respiratory device ecosystem. A primary emphasis across market leaders is clinical validation: manufacturers are investing in targeted clinical studies and post-market evidence gathering to substantiate claims about lung-protective strategies, non-invasive efficacy, and device interoperability. These evidence-generation programs are increasingly designed in collaboration with leading neonatal centers to ensure relevance and to accelerate clinician acceptance.

Another common strategy is modular product architecture that supports both hardware longevity and software-driven feature upgrades. By decoupling core ventilator platforms from optional analytics and connectivity modules, manufacturers can offer scalable solutions to diverse customers while preserving upgrade pathways. Service models are likewise evolving; companies are expanding remote diagnostics, predictive maintenance, and outcome-oriented service contracts to reduce downtime and enhance value capture.

Partnerships and distribution strategies are also notable. Several firms are deepening relationships with local service providers, clinical training organizations, and technology firms to deliver comprehensive solutions rather than standalone devices. This trend aligns with health systems' preference for vendor partnerships that reduce integration burden and support clinical pathway improvements. Finally, new entrants and adjacent-technology players are pressing incumbents on pricing and feature innovation, particularly in non-invasive support and digital analytics, intensifying competition and accelerating product differentiation.

Practical strategic priorities for manufacturers and health systems to secure clinical adoption commercial resilience and regulatory alignment in neonatal respiratory care

Industry leaders should adopt a set of actionable priorities to maintain clinical relevance, commercial resilience, and regulatory compliance. First, invest in evidence-generation efforts that closely align with clinician priorities, focusing on outcomes that matter in neonatal care such as lung-protection metrics, extubation success, and reduced length of respiratory support. By prioritizing pragmatic clinical studies and real-world data collection, organizations can shorten the time between innovation and clinical adoption.

Second, design product roadmaps around modularity and software-upgrade pathways that allow customers to scale functionality without full hardware replacement. This approach supports total cost of ownership considerations and fosters long-term relationships. Third, strengthen supply chain flexibility by qualifying secondary suppliers, exploring nearshoring or regional assembly options, and structuring contracts to mitigate tariff and logistics variability. These measures will reduce procurement friction and enhance market responsiveness.

Fourth, expand service offerings to include predictive maintenance, remote training, and analytics-enabled clinical decision support, thereby creating recurring revenue streams and deeper integration into care pathways. Fifth, tailor go-to-market strategies to regional needs: offer robust, serviceable devices and training in resource-constrained settings while emphasizing connectivity and advanced ventilation modes in well-resourced tertiary centers. Finally, engage early with regulatory authorities and clinical leaders to co-design implementation plans that address safety, interoperability, and usability, ensuring smoother product introductions and sustained clinical adoption.

A robust mixed method research approach combining clinician interviews documentary review and iterative expert validation to ensure clinically grounded operational insights

The research methodology underpinning this analysis combines primary qualitative engagement, systematic secondary review, and rigorous data validation to produce actionable insights. Primary methods included in-depth interviews with clinicians, respiratory therapists, clinical engineers, and procurement leaders across neonatal units, supplemented by structured discussions with product and regulatory leaders within manufacturing organizations. These conversations provided nuanced perspectives on clinical priorities, device usability, and procurement constraints.

Secondary methods entailed a structured review of peer-reviewed clinical literature, regulatory guidance documents, device technical specifications, and publicly available clinical study registries to map technology attributes, safety considerations, and published outcomes. In addition, device manuals and training materials were analyzed to understand consumable requirements, maintenance intervals, and staff training demands. Triangulation across these sources enabled validation of thematic findings and identification of areas requiring further primary inquiry.

Data quality assurance included cross-validation of interview insights against documentary evidence and iterative review cycles with subject-matter experts to confirm clinical interpretations and operational implications. Where divergent viewpoints emerged, follow-up inquiries were conducted to reconcile differences and to ensure that conclusions reflect a broad and representative set of practitioner experiences. This mixed-method approach supports conclusions that are both clinically grounded and operationally relevant.

Synthesis of clinical technological and commercial imperatives that determine future readiness and impact in neonatal respiratory device ecosystems

In conclusion, neonatal intensive care respiratory devices are positioned at a strategic inflection point driven by clinical priorities, technological innovation, and evolving procurement dynamics. Non-invasive strategies, advanced ventilation modes, and digital integration are converging to create new expectations for device performance, evidence, and service models. At the same time, tariff dynamics and regional heterogeneity require adaptive supply chain and go-to-market approaches that balance cost, availability, and clinical needs.

Moving forward, organizations that align product development with clinician-validated outcomes, adopt modular and upgradeable architectures, and invest in integrated service offerings will be best placed to support neonatal care teams and capture long-term value. Equally important is the ability to navigate regulatory pathways and to offer tailored solutions across diverse regional contexts. By synthesizing clinical, operational, and commercial considerations, stakeholders can make informed decisions that enhance neonatal outcomes while sustaining organizational performance.

This conclusion underscores the imperative for coordinated action across manufacturers, health systems, and policy-makers to ensure that technological advances translate into safer, more effective, and more accessible respiratory care for the smallest patients.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of artificial intelligence algorithms for predictive neonatal ventilator management
  • 5.2. Adoption of high flow nasal cannula systems to reduce invasive ventilation in preterm infants
  • 5.3. Development of portable neonatal ventilators enabling home-based respiratory support for infants
  • 5.4. Implementation of real-time wireless monitoring platforms for remote neonatal respiratory therapy oversight
  • 5.5. Advancement in precision oxygen delivery modules to optimize neonatal respiratory outcomes
  • 5.6. U.S. FDA accelerated approval pathways fueling innovation in neonatal intensive care respiratory devices
  • 5.7. Integration of antimicrobial and biocompatible coatings on ventilator interfaces to prevent infections
  • 5.8. Rising demand for eco-friendly and disposable respiratory consumables in neonatal intensive care units
  • 5.9. Emergence of telehealth-enabled neonatal respiratory devices for rural and underserved populations
  • 5.10. Use of nanomaterial-based filters in neonatal ventilators for enhanced air purity and safety

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Neonatal Intensive Care Respiratory Devices Market, by Product Type

  • 8.1. Continuous Positive Airway Pressure Devices
  • 8.2. Conventional Ventilators
  • 8.3. High-Frequency Ventilators
  • 8.4. Oxygen Hoods

9. Neonatal Intensive Care Respiratory Devices Market, by Technology

  • 9.1. Invasive Respiratory Support
    • 9.1.1. Conventional Mechanical Ventilation
      • 9.1.1.1. Dual-Controlled Ventilation
      • 9.1.1.2. Pressure Controlled Ventilation
      • 9.1.1.3. Volume Controlled Ventilation
    • 9.1.2. High-Frequency Oscillatory Ventilation
  • 9.2. Non-Invasive Respiratory Support
    • 9.2.1. Continuous Positive Airway Pressure Therapy
    • 9.2.2. Non-Invasive Positive Pressure Ventilation

10. Neonatal Intensive Care Respiratory Devices Market, by Mode

  • 10.1. Dual-Controlled Ventilation
  • 10.2. Pressure Controlled Ventilation
  • 10.3. Volume Controlled Ventilation

11. Neonatal Intensive Care Respiratory Devices Market, by End User

  • 11.1. Clinics
  • 11.2. Hospitals
  • 11.3. Specialty Care Centers

12. Neonatal Intensive Care Respiratory Devices Market, by Application

  • 12.1. Apnea Monitoring
  • 12.2. Oxygen Therapy
  • 12.3. Weaning Support

13. Neonatal Intensive Care Respiratory Devices Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Neonatal Intensive Care Respiratory Devices Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Neonatal Intensive Care Respiratory Devices Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Koninklijke Philips N.V.
    • 16.3.2. General Electric Company
    • 16.3.3. Dragerwerk AG & Co. KGaA
    • 16.3.4. Medtronic plc
    • 16.3.5. Fisher & Paykel Healthcare Corporation Limited
    • 16.3.6. Hamilton Medical AG
    • 16.3.7. Smiths Group plc
    • 16.3.8. Becton, Dickinson and Company
    • 16.3.9. ResMed Inc.
    • 16.3.10. Natus Medical Incorporated

LIST OF FIGURES

  • FIGURE 1. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONTINUOUS POSITIVE AIRWAY PRESSURE DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONTINUOUS POSITIVE AIRWAY PRESSURE DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONTINUOUS POSITIVE AIRWAY PRESSURE DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONTINUOUS POSITIVE AIRWAY PRESSURE DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONTINUOUS POSITIVE AIRWAY PRESSURE DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONTINUOUS POSITIVE AIRWAY PRESSURE DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONVENTIONAL VENTILATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONVENTIONAL VENTILATORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONVENTIONAL VENTILATORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONVENTIONAL VENTILATORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONVENTIONAL VENTILATORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONVENTIONAL VENTILATORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY HIGH-FREQUENCY VENTILATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY HIGH-FREQUENCY VENTILATORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY HIGH-FREQUENCY VENTILATORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY HIGH-FREQUENCY VENTILATORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY HIGH-FREQUENCY VENTILATORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY HIGH-FREQUENCY VENTILATORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY OXYGEN HOODS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY OXYGEN HOODS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY OXYGEN HOODS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY OXYGEN HOODS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY OXYGEN HOODS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY OXYGEN HOODS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE RESPIRATORY SUPPORT, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE RESPIRATORY SUPPORT, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE RESPIRATORY SUPPORT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE RESPIRATORY SUPPORT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE RESPIRATORY SUPPORT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE RESPIRATORY SUPPORT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE RESPIRATORY SUPPORT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE RESPIRATORY SUPPORT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONVENTIONAL MECHANICAL VENTILATION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONVENTIONAL MECHANICAL VENTILATION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONVENTIONAL MECHANICAL VENTILATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONVENTIONAL MECHANICAL VENTILATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONVENTIONAL MECHANICAL VENTILATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONVENTIONAL MECHANICAL VENTILATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONVENTIONAL MECHANICAL VENTILATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONVENTIONAL MECHANICAL VENTILATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY DUAL-CONTROLLED VENTILATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY DUAL-CONTROLLED VENTILATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY DUAL-CONTROLLED VENTILATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY DUAL-CONTROLLED VENTILATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY DUAL-CONTROLLED VENTILATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY DUAL-CONTROLLED VENTILATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY PRESSURE CONTROLLED VENTILATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY PRESSURE CONTROLLED VENTILATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY PRESSURE CONTROLLED VENTILATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY PRESSURE CONTROLLED VENTILATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY PRESSURE CONTROLLED VENTILATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY PRESSURE CONTROLLED VENTILATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY VOLUME CONTROLLED VENTILATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY VOLUME CONTROLLED VENTILATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY VOLUME CONTROLLED VENTILATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY VOLUME CONTROLLED VENTILATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY VOLUME CONTROLLED VENTILATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY VOLUME CONTROLLED VENTILATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY HIGH-FREQUENCY OSCILLATORY VENTILATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY HIGH-FREQUENCY OSCILLATORY VENTILATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY HIGH-FREQUENCY OSCILLATORY VENTILATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY HIGH-FREQUENCY OSCILLATORY VENTILATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY HIGH-FREQUENCY OSCILLATORY VENTILATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY HIGH-FREQUENCY OSCILLATORY VENTILATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY NON-INVASIVE RESPIRATORY SUPPORT, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY NON-INVASIVE RESPIRATORY SUPPORT, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY NON-INVASIVE RESPIRATORY SUPPORT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY NON-INVASIVE RESPIRATORY SUPPORT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY NON-INVASIVE RESPIRATORY SUPPORT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY NON-INVASIVE RESPIRATORY SUPPORT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY NON-INVASIVE RESPIRATORY SUPPORT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY NON-INVASIVE RESPIRATORY SUPPORT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONTINUOUS POSITIVE AIRWAY PRESSURE THERAPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONTINUOUS POSITIVE AIRWAY PRESSURE THERAPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONTINUOUS POSITIVE AIRWAY PRESSURE THERAPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONTINUOUS POSITIVE AIRWAY PRESSURE THERAPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONTINUOUS POSITIVE AIRWAY PRESSURE THERAPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONTINUOUS POSITIVE AIRWAY PRESSURE THERAPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY NON-INVASIVE POSITIVE PRESSURE VENTILATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY NON-INVASIVE POSITIVE PRESSURE VENTILATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY NON-INVASIVE POSITIVE PRESSURE VENTILATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY NON-INVASIVE POSITIVE PRESSURE VENTILATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY NON-INVASIVE POSITIVE PRESSURE VENTILATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY NON-INVASIVE POSITIVE PRESSURE VENTILATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY DUAL-CONTROLLED VENTILATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY DUAL-CONTROLLED VENTILATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY DUAL-CONTROLLED VENTILATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY DUAL-CONTROLLED VENTILATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY DUAL-CONTROLLED VENTILATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY DUAL-CONTROLLED VENTILATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY PRESSURE CONTROLLED VENTILATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY PRESSURE CONTROLLED VENTILATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY PRESSURE CONTROLLED VENTILATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY PRESSURE CONTROLLED VENTILATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY PRESSURE CONTROLLED VENTILATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY PRESSURE CONTROLLED VENTILATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY VOLUME CONTROLLED VENTILATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY VOLUME CONTROLLED VENTILATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY VOLUME CONTROLLED VENTILATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY VOLUME CONTROLLED VENTILATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY VOLUME CONTROLLED VENTILATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY VOLUME CONTROLLED VENTILATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY SPECIALTY CARE CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY SPECIALTY CARE CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY SPECIALTY CARE CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY SPECIALTY CARE CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY SPECIALTY CARE CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY SPECIALTY CARE CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY APNEA MONITORING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY APNEA MONITORING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY APNEA MONITORING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY APNEA MONITORING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY APNEA MONITORING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY APNEA MONITORING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY OXYGEN THERAPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY OXYGEN THERAPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY OXYGEN THERAPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY OXYGEN THERAPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY OXYGEN THERAPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY OXYGEN THERAPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY WEANING SUPPORT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY WEANING SUPPORT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY WEANING SUPPORT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY WEANING SUPPORT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY WEANING SUPPORT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY WEANING SUPPORT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 155. AMERICAS NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 156. AMERICAS NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 157. AMERICAS NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 158. AMERICAS NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 159. AMERICAS NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 160. AMERICAS NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 161. AMERICAS NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE RESPIRATORY SUPPORT, 2018-2024 (USD MILLION)
  • TABLE 162. AMERICAS NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE RESPIRATORY SUPPORT, 2025-2032 (USD MILLION)
  • TABLE 163. AMERICAS NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONVENTIONAL MECHANICAL VENTILATION, 2018-2024 (USD MILLION)
  • TABLE 164. AMERICAS NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONVENTIONAL MECHANICAL VENTILATION, 2025-2032 (USD MILLION)
  • TABLE 165. AMERICAS NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY NON-INVASIVE RESPIRATORY SUPPORT, 2018-2024 (USD MILLION)
  • TABLE 166. AMERICAS NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY NON-INVASIVE RESPIRATORY SUPPORT, 2025-2032 (USD MILLION)
  • TABLE 167. AMERICAS NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2018-2024 (USD MILLION)
  • TABLE 168. AMERICAS NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2025-2032 (USD MILLION)
  • TABLE 169. AMERICAS NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 170. AMERICAS NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 171. AMERICAS NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 172. AMERICAS NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 173. NORTH AMERICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. NORTH AMERICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 176. NORTH AMERICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 178. NORTH AMERICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 179. NORTH AMERICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE RESPIRATORY SUPPORT, 2018-2024 (USD MILLION)
  • TABLE 180. NORTH AMERICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE RESPIRATORY SUPPORT, 2025-2032 (USD MILLION)
  • TABLE 181. NORTH AMERICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONVENTIONAL MECHANICAL VENTILATION, 2018-2024 (USD MILLION)
  • TABLE 182. NORTH AMERICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONVENTIONAL MECHANICAL VENTILATION, 2025-2032 (USD MILLION)
  • TABLE 183. NORTH AMERICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY NON-INVASIVE RESPIRATORY SUPPORT, 2018-2024 (USD MILLION)
  • TABLE 184. NORTH AMERICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY NON-INVASIVE RESPIRATORY SUPPORT, 2025-2032 (USD MILLION)
  • TABLE 185. NORTH AMERICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2018-2024 (USD MILLION)
  • TABLE 186. NORTH AMERICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2025-2032 (USD MILLION)
  • TABLE 187. NORTH AMERICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 188. NORTH AMERICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 189. NORTH AMERICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 190. NORTH AMERICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 191. LATIN AMERICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. LATIN AMERICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. LATIN AMERICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 194. LATIN AMERICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 195. LATIN AMERICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 196. LATIN AMERICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 197. LATIN AMERICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE RESPIRATORY SUPPORT, 2018-2024 (USD MILLION)
  • TABLE 198. LATIN AMERICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE RESPIRATORY SUPPORT, 2025-2032 (USD MILLION)
  • TABLE 199. LATIN AMERICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONVENTIONAL MECHANICAL VENTILATION, 2018-2024 (USD MILLION)
  • TABLE 200. LATIN AMERICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONVENTIONAL MECHANICAL VENTILATION, 2025-2032 (USD MILLION)
  • TABLE 201. LATIN AMERICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY NON-INVASIVE RESPIRATORY SUPPORT, 2018-2024 (USD MILLION)
  • TABLE 202. LATIN AMERICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY NON-INVASIVE RESPIRATORY SUPPORT, 2025-2032 (USD MILLION)
  • TABLE 203. LATIN AMERICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2018-2024 (USD MILLION)
  • TABLE 204. LATIN AMERICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2025-2032 (USD MILLION)
  • TABLE 205. LATIN AMERICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 206. LATIN AMERICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 207. LATIN AMERICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 208. LATIN AMERICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 209. EUROPE, MIDDLE EAST & AFRICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 210. EUROPE, MIDDLE EAST & AFRICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 211. EUROPE, MIDDLE EAST & AFRICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 212. EUROPE, MIDDLE EAST & AFRICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 213. EUROPE, MIDDLE EAST & AFRICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 214. EUROPE, MIDDLE EAST & AFRICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 215. EUROPE, MIDDLE EAST & AFRICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE RESPIRATORY SUPPORT, 2018-2024 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE RESPIRATORY SUPPORT, 2025-2032 (USD MILLION)
  • TABLE 217. EUROPE, MIDDLE EAST & AFRICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONVENTIONAL MECHANICAL VENTILATION, 2018-2024 (USD MILLION)
  • TABLE 218. EUROPE, MIDDLE EAST & AFRICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONVENTIONAL MECHANICAL VENTILATION, 2025-2032 (USD MILLION)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY NON-INVASIVE RESPIRATORY SUPPORT, 2018-2024 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY NON-INVASIVE RESPIRATORY SUPPORT, 2025-2032 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2018-2024 (USD MILLION)
  • TABLE 222. EUROPE, MIDDLE EAST & AFRICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2025-2032 (USD MILLION)
  • TABLE 223. EUROPE, MIDDLE EAST & AFRICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 224. EUROPE, MIDDLE EAST & AFRICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 225. EUROPE, MIDDLE EAST & AFRICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 226. EUROPE, MIDDLE EAST & AFRICA NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 227. EUROPE NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 228. EUROPE NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 229. EUROPE NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 230. EUROPE NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 231. EUROPE NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 232. EUROPE NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 233. EUROPE NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE RESPIRATORY SUPPORT, 2018-2024 (USD MILLION)
  • TABLE 234. EUROPE NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE RESPIRATORY SUPPORT, 2025-2032 (USD MILLION)
  • TABLE 235. EUROPE NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONVENTIONAL MECHANICAL VENTILATION, 2018-2024 (USD MILLION)
  • TABLE 236. EUROPE NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY CONVENTIONAL MECHANICAL VENTILATION, 2025-2032 (USD MILLION)
  • TABLE 237. EUROPE NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY NON-INVASIVE RESPIRATORY SUPPORT, 2018-2024 (USD MILLION)
  • TABLE 238. EUROPE NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY NON-INVASIVE RESPIRATORY SUPPORT, 2025-2032 (USD MILLION)
  • TABLE 239. EUROPE NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2018-2024 (USD MILLION)
  • TABLE 240. EUROPE NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2025-2032 (USD MILLION)
  • TABLE 241. EUROPE NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 242. EUROPE NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 243. EUROPE NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 244. EUROPE NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 245. MIDDLE EAST NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 246. MIDDLE EAST NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MAR